| Literature DB >> 32540992 |
Pierre-Grégoire Coulon1, Soumyabrata Roy1, Swayam Prakash1, Ruchi Srivastava1, Nisha Dhanushkodi1, Stephanie Salazar1, Cassandra Amezquita1, Lan Nguyen1, Hawa Vahed1, Angela M Nguyen1, Wasay R Warsi1, Caitlin Ye1, Edgar A Carlos-Cruz1, Uyen T Mai1, Lbachir BenMohamed2,3,4.
Abstract
A large proportion of the world's population harbors latent HSV type 1 (HSV-1). Cross-talk between antiviral CD8+ T cells and HSV-1 appear to control latency/reactivation cycles. We found that compared with healthy asymptomatic individuals, in symptomatic (SYMP) patients, the CD8+ T cells with the same HLA-A*0201-restricted HSV-1 epitope specificities expressed multiple genes and proteins associated to major T cell exhaustion pathways and were dysfunctional. Blockade of immune checkpoints with anti-LAG-3 and anti-PD-1 antagonist mAbs synergistically restored the frequency and function of antiviral CD8+ T cells, both 1) ex vivo, in SYMP individuals and SYMP HLA-A*0201 transgenic mice; and 2) in vivo in HSV-1-infected SYMP HLA-A*0201 transgenic mice. This was associated with a significant reduction in virus reactivation and recurrent ocular herpetic disease. These findings confirm antiviral CD8+ T cell exhaustion during SYMP herpes infection and pave the way to targeting immune checkpoints to combat recurrent ocular herpes.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32540992 PMCID: PMC7343593 DOI: 10.4049/jimmunol.2000131
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.426